英文名称 |
中文名称 |
CAS号 |
操作 |
Safimaltib |
1H-Pyrazole-4-carboxamide, 1-(1,2-dihydro-1-oxo-5-isoquinolinyl)-5-(trifluoromethyl)-N-[2-(trifluoromethyl)-4-pyridinyl]- |
2230273-76-2 |
详细
|
ZL0590 |
化合物ZL0590 |
2230496-99-6 |
详细
|
AP1867-2-(carboxymethoxy) |
FKBP12 LIGAND |
2230613-03-1 |
详细
|
EHMT2-IN-1 |
EHMT2-IN-1 |
2230849-55-3 |
详细
|
INCB086550 |
INCB084550 |
2230911-59-6 |
详细
|
NCT-505 |
NCT-505 |
2231079-74-4 |
详细
|
NCT-506 |
NCT-506 |
2231098-99-8 |
详细
|
IDH1 Inhibitor 1 |
IDH1 INHIBITOR 1 |
2234285-81-3 |
详细
|
ONO-4817 |
N-[(1S,3S)-1-[(ETHOXYMETHOXY)METHYL]-4-(HYDROXYAMINO)-3-METHYL-4-OXOBUTYL]-4-PHENOXYBENZAMIDE |
223472-31-9 |
详细
|
EZH2-IN-2 |
EZH2-A€IN-A€2 |
2238821-31-1 |
详细
|
Londamocitinib |
JAK1-IN-7 |
2241039-81-4 |
详细
|
Bemnifosbuvir hemisulfate |
AT-527 |
2241337-84-6 |
详细
|
JNJ4796 |
JNJ4796 |
2241664-16-2 |
详细
|
BTK inhibitor 10 |
BTK inhibitor 10 |
2241732-30-7 |
详细
|
CMPD-39 |
化合物USP30 INHIBITOR 18 |
2242582-40-5 |
详细
|
BMS-986299 |
BMS986299 |
2242952-69-6 |
详细
|
WEE1-IN-5 |
化合物DEBIO-0123 |
2243882-74-6 |
详细
|
Alloxan hydrate |
阿脲一水合物 |
2244-11-3 |
详细
|
STING-IN-3 |
化合物C-171 |
2244881-69-2 |
详细
|
CDK12-IN-2 |
化合物CDK12-IN-2 |
2244987-03-7 |
详细
|
HeE1-2Tyr |
化合物HEE1-2TYR |
2245195-67-7 |
详细
|
MERS-CoV-IN-1 |
化合物MERS-COV-IN-1 |
2245697-92-9 |
详细
|
DI-591 |
DI-591 |
2245887-38-9 |
详细
|
CAY10746 |
CAY10746 |
2247240-76-0 |
详细
|
BAY-6035 |
BAY-6035 |
2247890-13-5 |
详细
|
SN-008 |
化合物SN-008 |
2249106-01-0 |
详细
|
IDRA 21 |
7-氯-3-甲基-3,4-二氢-2H-1,2,4-苯并噻二嗪 1,1-二氧化物 |
22503-72-6 |
详细
|
Cathepsin inhibitor 1 |
Cathepsin Inhibitor 1 |
225120-65-0 |
详细
|
Epitinib succinate |
琥珀酸EPITINIB |
2252334-12-4 |
详细
|
DDO-7263 |
化合物DDO-7263 |
2254004-96-9 |
详细
|
ZX-29 |
ZX-29 |
2254805-62-2 |
详细
|
2-Phenylethyl isothiocyanate |
2-苯基乙基异硫代氰酸酯 |
2257-09-2 |
详细
|
STING agonist-12 |
STING AGONIST-12 |
2259624-71-8 |
详细
|
Cyclothiazide |
莰烯氯噻嗪 |
2259-96-3 |
详细
|
Monaschromone |
苦楝萜酮内酯 |
22611-36-5 |
详细
|
SM-360320 |
6-氨基-7,9-二氢-2-(2-甲氧基乙氧基)-9-(苯甲基)-8H-嘌呤-8-酮 |
226907-52-4 |
详细
|
Tuspetinib |
化合物HM43239 |
2294874-49-8 |
详细
|
FLT3-IN-4 |
FLT3-IN-4 |
2304799-09-3 |
详细
|
MARK4 inhibitor 1 |
MARK4 inhibitor 1 |
2271081-58-2 |
详细
|
BAY 2666605 |
化合物BAY 2666605 |
2275774-60-0 |
详细
|
Maralixibat chloride |
HP-625) |
228113-66-4 |
详细
|
Pratensein |
红车轴草素 |
2284-31-3 |
详细
|
VULM 1457 |
VULM 1457 |
228544-65-8 |
详细
|
E64FC26 |
E64FC26 |
2285446-62-8 |
详细
|
Bractoppin |
Bractoppin |
2290527-07-8 |
详细
|
IU1-248 |
Benzonitrile, 4-[3-[2-(4-hydroxy-1-piperidinyl)acetyl]-2,5-dimethyl-1H-pyrrol-1-yl]- |
2307472-03-1 |
详细
|
Matairesinoside |
罗汉松脂苷 |
23202-85-9 |
详细
|
HPK1-IN-7 |
1(3H)-Isobenzofuranone, 5-[[4-[[(1S)-2-hydroxy-1-phenylethyl]amino]-5-(1,3,4-oxadiazol-2-yl)-2-pyrimidinyl]amino]-3,3-dimethyl- |
2320462-65-3 |
详细
|
MAGL-IN-1 |
MAGL-IN-1 |
2324160-91-8 |
详细
|
ACSS2-IN-2 |
化合物ACSS2-IN-2 |
2332820-04-7 |
详细
|
PARP/PI3K-IN-1 |
CAY10749 |
2337386-47-5 |
详细
|
Djalonensone |
交链孢霉甲基醚 |
23452-05-3 |
详细
|
15-LOX-1 inhibitor 1 |
9C(I472) |
2349374-37-2 |
详细
|
GA-017 |
化合物GA-017 |
2351906-74-4 |
详细
|
Enbezotinib |
TPX-0046 |
2359649-81-1 |
详细
|
RBN-3143 |
PARP14抑制剂 |
2360853-16-1 |
详细
|
AES-135 |
AES-135 |
2361659-61-0 |
详细
|
MS31 |
MS31 |
2366264-12-0 |
详细
|
Zanzalintinib |
XL092 |
2367004-54-2 |
详细
|
BRM/BRG1 ATP Inhibitor-2 |
化合物 BRM/BRG1 ATP INHIBITOR-2 |
2368900-77-8 |
详细
|
G140 |
化合物G140 |
2369751-07-3 |
详细
|
(S)-Sunvozertinib |
2-Propenamide, N-[5-[[4-[[5-chloro-4-fluoro-2-(1-hydroxy-1-methylethyl)phenyl]amino]-2-pyrimidinyl]amino]-2-[(3S)-3-(dimethylamino)-1-pyrrolidinyl]-4-methoxyphenyl]- |
2370013-49-1 |
详细
|
Evixapodlin |
(5S,5'S)-5,5'-((((5,5'-(2,2'-dichloro-[1,1'-biphenyl]-3,3'-diyl)bis(3-methoxypyrazine-5,2-diyl))bis(methylene))bis(azanediyl))bis(methylene))bis(pyrrolidin-2-one) |
2374856-75-2 |
详细
|
M2N12 |
M2N12 |
2376577-06-7 |
详细
|
SU056 |
|
2376580-08-2 |
详细
|
Migoprotafib |
抑制剂 |
2377352-49-1 |
详细
|
BAY-3827 |
BAY-3827 |
2377576-35-5 |
详细
|
SCR130 |
1,7,9-Triazaspiro[4.5]dec-1-ene-6,10-dione, 2,4-bis(4-chlorophenyl)-8-thioxo- |
2377858-38-1 |
详细
|
PD-1/PD-L1-IN-NP19 |
化合物PD-1/PD-L1-IN-NP19 |
2377916-66-8 |
详细
|
HWL-088 |
HWL-088 |
2378617-96-8 |
详细
|
Reverse transcriptase-IN-1 |
Reverse transcriptase-IN-1 |
2380001-43-2 |
详细
|
Nampt-IN-5 |
化合物NAMPT-IN-5 |
2380013-17-0 |
详细
|
PF-07220060 |
CDK4/6-IN-6 |
2380321-51-5 |
详细
|
NF-κΒ activator 1 |
|
2387524-59-4 |
详细
|
JAK2/FLT3-IN-1 |
JAK2/FLT3-IN-1 |
2387765-27-5 |
详细
|
Anhydroerythromycin A |
脱水红霉素 |
23893-13-2 |
详细
|
EB-42486 |
化合物EB-42486 |
2390475-81-5 |
详细
|
Pumecitinib |
|
2401057-12-1 |
详细
|
JQAD1 |
化合物JQAD1 |
2417097-18-6 |
详细
|
KB-0742 dihydrochloride |
KB-0742 dihydrochloride |
2416874-75-2 |
详细
|
Evifacotrep |
依法曲普 |
2413739-88-3 |
详细
|
EZM0414 |
EZM0414 |
2411748-50-8 |
详细
|
XL177A |
化合物XL177A |
2417089-74-6 |
详细
|
Camonsertib |
(3-内)-3-[6-[(3R)-3-甲基-4-吗啉基]-1-(1H-吡唑-3-基)-1H-吡唑并[3,4-B]吡啶-4-基]-8-氧杂双环[3.2.1]辛-3-醇 |
2417489-10-0 |
详细
|
Terameprocol |
EM-1421 |
24150-24-1 |
详细
|
WDR5-IN-1 |
WDR5-IN-1 |
2408842-51-1 |
详细
|
CA77.1 |
化合物CA77.1 |
2412270-22-3 |
详细
|
Adaphostin |
化合物ADAPHOSTIN |
241127-58-2 |
详细
|
JKE-1674 |
JKE-1674 |
2421119-60-8 |
详细
|
ATX inhibitor 5 |
ATX inhibitor 5 |
2402772-45-4 |
详细
|
Geranylgeraniol |
香叶基香叶醇 |
24034-73-9 |
详细
|
TP0586532 |
TP0586532 |
2427584-96-9 |
详细
|
Palmitic acid- |
化合物NCT-58 |
2411429-33-7 |
详细
|
JR14a |
JR14a |
2411440-41-8 |
详细
|
Sovilnesib |
Sovilnesib |
2410796-79-9 |
详细
|
IHMT-MST1-58 |
化合物 IHMT-MST1-58 |
2414484-25-4 |
详细
|
ASK1-IN-1 |
N-(6-(4-异丙基-4H-1,2,4-三唑-3-基)吡啶-2-基)-3-甲氧基-1-(吡嗪-2-基)-1H-吡唑-4-甲酰胺 |
2411382-24-4 |
详细
|
HS271 |
化合物HS271 |
2410393-15-4 |
详细
|
PLN-1474 |
PLN1474 |
2408065-32-5 |
详细
|
SY-5609 |
7-(二甲基膦基)-3-[2-[[(3S)-6,6-二甲基-3-哌啶基]氨基]-5-(三氟甲基)-4-嘧啶基]-1H-吲哚-6-甲腈 |
2417302-07-7 |
详细
|